Last reviewed · How we verify

NCT03497741

Predictive Value of Procalcitonin for Bacteremia in the ICU

Completed Last updated 21 June 2024
What this trial tests

trial testing procalcitonin measurement in Sepsis in 170 participants. Completed in 1 March 2019.

Timeline
1 October 2017
Primary endpoint
1 January 2019
1 March 2019

Quick facts

Lead sponsorRijnstate Hospital
StatusCompleted
Study typeOBSERVATIONAL
Enrollment170
Start date1 October 2017
Primary completion1 January 2019
Estimated completion1 March 2019
Sites1 location across Netherlands

Drugs / interventions tested

Conditions studied

Sponsor

Rijnstate Hospital

Who can join

18 and older, any sex, with Sepsis or Procalcitonin. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Association between plasma procalcitonin levels and positive blood cultures in critical illness patients in the ICU.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Sepsis

Currently open trials in the same condition.

Other Rijnstate Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03497741.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing